Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | ABBV:NYQ since announced | Transaction value |
---|---|---|
Cerevel Therapeutics Holdings Inc | 19.19% | 8.62bn |
ImmunoGen Inc | 24.42% | 10.22bn |
Data delayed at least 15 minutes, as of Jul 19 2024 21:10 BST.
0.00%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
Caixa DTVM SAas of 31 Mar 2024 | 410.42k | 0.00% |
Bram Bradesco Asset Management S/A DTVMas of 31 Mar 2024 | 60.38k | 0.00% |
Daycoval Asset Management Administra��o de Recursos Ltda.as of 31 Mar 2024 | 3.65k | 0.00% |
XP Allocation Asset Management Ltda.as of 31 Mar 2024 | 1.98k | 0.00% |
BB Gest�o de Recursos DTVM SAas of 31 Mar 2024 | 0.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 18 Jul 2024Source: FactSet Research Systems Inc.